Stakeholder Reflections on Implementing the National Institutes of Health's Policy on Single Institutional Review Boards
Ethics & Human Research · 2023
DOI: 10.1002/eahr.500179 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ethics & Human Research, 2023. Verfasst von Amy Corneli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Associate professor in the Department of Population Health Sciences, a faculty member at the Duke Clinical Research Institute, and a lead social scie…. Hauptthemen laut MEDLINE: Biomedical Research. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The National Institutes of Health (NIH) requires use of a single institutional review board (sIRB) for multisite, nonexempt, NIH‐funded research with human participants. The Clinical Trials Transformation Initiative (CTTI) conducted in‐depth interviews with 34 stakeholders at two universities and in research administration leadership positions at multiple institutions about their experiences implementing the sIRB model, focusing on the NIH policy's goals soon after the policy was enacted. While some stakeholders suggested that using an sIRB has streamlined and reduced inefficiencies associated with the local IRB model, more stakeholders indicated that the sIRB model has not simplified the ethics review process and instead created new inefficiencies due to unclear roles and responsibilities for staff and institutions; a lack of systems and processes for implementing the sIRB model, including communication systems; and increased workloads. CTTI used these findings to propose a new framework for evaluating the NIH sIRB policy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Associate professor in the Department of Population Health Sciences, a faculty member at the Duke Clinical Research Institute, and a lead social scientist of the Clinical Trials Transformation Initiative at Duke Univers…
- Research program leader in the Department of Population Health Sciences and a senior research associate of the Clinical Trials Transformation Initiative at Duke University School of Medicine.
- Research program leader in the Department of Population Health Sciences and a research associate of the Clinical Trials Transformation Initiative at Duke University School of Medicine.
- Director of projects in the Clinical Trials Transformation Initiative at Duke Clinical Research Institute at Duke University.
- Associate dean of clinical and translational research in the Department of Health Sciences at the University of California, San Diego.
- Executive director of North Star Review Board in Freeport, ME.
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Corneli, A., McKenna, K., Hanlen-Rosado, E., Calvert, S. B., Mah, E., & Rosenfeld, S. J. (2023). Stakeholder Reflections on Implementing the National Institutes of Health's Policy on Single Institutional Review Boards. Ethics & Human Research. https://doi.org/10.1002/eahr.500179
Vancouver
Corneli A, McKenna K, Hanlen-Rosado E, Calvert SB, Mah E, Rosenfeld SJ. Stakeholder Reflections on Implementing the National Institutes of Health's Policy on Single Institutional Review Boards. Ethics & Human Research. 2023. doi:10.1002/eahr.500179
BibTeX
@article{Corneli2023,
author = {Corneli, Amy and McKenna, Kevin and Hanlen-Rosado, Emily and Calvert, Sara B and Mah, Eric and Rosenfeld, Stephen J},
title = {Stakeholder Reflections on Implementing the National Institutes of Health's Policy on Single Institutional Review Boards},
journal = {Ethics & Human Research},
year = {2023},
doi = {10.1002/eahr.500179}
}
EUVIMED